Queen’s University leading UK-wide trial to measure COVID-19 antibodies in children

Press/Media: Research

Description

Queen’s University Belfast is leading a UK-wide trial called ‘Seroprevalence of SARS-Cov-2 infection in healthy children’ to measure antibodies to SARS-CoV-2 (COVID-19) in healthy children. 

Period15 Jun 2020

Media coverage

1

Media coverage

  • TitleQueen’s University leading UK-wide trial to measure COVID-19 antibodies in children
    Degree of recognitionNational
    Media name/outletHSC R&D Division Northern Ireland
    Media typeWeb
    Country/TerritoryUnited Kingdom
    Date15/06/2020
    DescriptionQueen’s University Belfast is leading a UK-wide trial called ‘Seroprevalence of SARS-Cov-2 infection in healthy children’ to measure antibodies to SARS-CoV-2 (COVID-19) in healthy children.
    URLhttps://research.hscni.net/uk-wide-trial-measure-covid-19-antibodies-children
    PersonsLisa McFetridge
View all 1
View less